Diabetes drug Ozempic is costing Medicare billions of dollars

Hosted by

New analysis from the Kaiser Family Foundation shows that Medicare spending on weight loss drugs like Ozempic rose to $5.7 billion in 2022 — up from $57 million in 2018.

Credits

Guest:

  • Juliette Cubanski - deputy director of the Kaiser Family Foundation’s program on Medicare policy

Host:

Jonathan Bastian

Producers:

Sarah Sweeney, Angie Perrin, Amy Ta, Brian Hardzinski, Bennett Purser, Kelsey Ngante, Zeke Reed, Andrea Brody, Jack Ross